no injection glp 1 Next Step GLP1 Stopping GLP-1 Medication: No. 1
Description
Yes, there are better alternatives if you want real GLP-1 care with medical support
A weight loss greater than 10% (therapeutic target in NAFLD) was achieved in 70.9% of semaglutide-treated patients and 25.6% of liraglutide-treated patients, with comparable rates of gastrointestinal adverse events [46]
Campos RV, Lee YC, Drucker DJ
For people who stop using GLP-1 weight-loss drugs such as Ozempic, gaining the weight back might be the least of their concerns
Therefore glucose metabolism needs to be closely monitored and treated in patients with pituitary adenomas
More importantly, the type of evidence is different
